- Home
- YMAB vs LWLG Comparison
YMAB vs LWLG Comparison
Compare YMAB & LWLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- LWLG
- Stock Information
- Founded
- YMAB 2015
- LWLG 1991
- Country
- YMAB United States
- LWLG United States
- Employees
- YMAB N/A
- LWLG N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- LWLG Containers/Packaging
- Sector
- YMAB Health Care
- LWLG Industrials
- Exchange
- YMAB Nasdaq
- LWLG Nasdaq
- Market Cap
- YMAB 386.7M
- LWLG 423.3M
- IPO Year
- YMAB 2018
- LWLG N/A
- Fundamental
- Price
- YMAB $8.61
- LWLG $3.01
- Analyst Decision
- YMAB Buy
- LWLG
- Analyst Count
- YMAB 10
- LWLG 0
- Target Price
- YMAB $13.91
- LWLG N/A
- AVG Volume (30 Days)
- YMAB 874.6K
- LWLG 2.5M
- Earning Date
- YMAB 11-07-2025
- LWLG 11-12-2025
- Dividend Yield
- YMAB N/A
- LWLG N/A
- EPS Growth
- YMAB N/A
- LWLG N/A
- EPS
- YMAB N/A
- LWLG N/A
- Revenue
- YMAB $85,385,000.00
- LWLG $94,355.00
- Revenue This Year
- YMAB N/A
- LWLG N/A
- Revenue Next Year
- YMAB $13.97
- LWLG N/A
- P/E Ratio
- YMAB N/A
- LWLG N/A
- Revenue Growth
- YMAB N/A
- LWLG 4.52
- 52 Week Low
- YMAB $3.55
- LWLG $0.79
- 52 Week High
- YMAB $16.11
- LWLG $4.23
- Technical
- Relative Strength Index (RSI)
- YMAB 81.21
- LWLG 54.30
- Support Level
- YMAB $8.50
- LWLG $2.98
- Resistance Level
- YMAB $8.56
- LWLG $3.42
- Average True Range (ATR)
- YMAB 0.02
- LWLG 0.34
- MACD
- YMAB -0.12
- LWLG -0.05
- Stochastic Oscillator
- YMAB 100.00
- LWLG 17.35
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About LWLG Lightwave Logic Inc.
Lightwave Logic Inc is a United States-based development stage company moving toward commercialization of next-generation electro-optic photonic devices made on its P2IC technology platform which uses in-house proprietary high-activity and high-stability organic polymers. Electro-optical devices convert data from electric signals into optical signals for multiple applications. It designs and synthesizes organic chromophores for use in its own proprietary electro-optic polymer systems and photonic device designs.